Infectious complications of immunosuppressive therapy in patients with rheumatic diseases

被引：86

作者：

Segal, BH

Sneller, MC

机构：

[1] NIAID,IMMUNOREGULAT LAB,NIH,BETHESDA,MD 20892

[2] NIAID,HOST DEF LAB,NIH,BETHESDA,MD 20892

来源：

RHEUMATIC DISEASE CLINICS OF NORTH AMERICA | 1997年 / 23卷 / 02期

关键词：

D O I：

10.1016/S0889-857X(05)70327-6

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Infection continues to be a major cause of morbidity and mortality in patients with rheumatic diseases. The recognition and treatment of infections in these patients is a particularly difficult task because the spectrum of potential pathogens is broad and the clinical manifestations of infection often mimic those of the underlying rheumatic disease. This article presents a general overview of the immunosuppressive properties of agents commonly used in the treatment of rheumatic diseases and focuses on specific pathogens associated with different immunosuppressive regimens. Also provided is a framework for the diagnostic evaluation and treatment of various infectious syndromes in patients with rheumatic diseases.

引用

页码：219 / &

页数：20

共 93 条

[1]

ABDOU NI, 1973, CLIN EXP IMMUNOL, V13, P55

[2]

ABOGUDDAH A, 1991, J RHEUMATOL, V18, P1403

[3] ALTERNATE-DAY STEROID THERAPY IN LUPUS NEPHRITIS [J].